Digital & AI Commercialisation
Build a commercial model and adoption plan for digital and AI-enabled Life Sciences solutions.
The commercial challenge
A promising technology still needs a defined use case, a buyer, an adoption pathway and a sustainable business model. Digital health customers also need confidence in evidence and the practical implications of deployment. RMC connects technology potential with customer demand and commercial execution.
How RMC can support you
Focus the opportunity — prioritise use cases, customer segments and buyers; distinguish technical capability from the problem customers will pay to solve.
Design the commercial model — explore pricing, packaging, partnerships and the assumptions behind a scalable proposition.
Plan adoption — map customer workflows and deployment dependencies; design pilots with commercial success criteria and a path beyond the pilot.
A practical engagement
01 Discover — test commercial assumptions through stakeholder discussions and available evidence.
02 Design — shape the proposition, business model and partnership approach.
03 Validate — build a pilot-to-scale roadmap with adoption, conversion and retention measures.
What you could leave with
A use-case and customer assessment; a commercial model with explicit assumptions; a partnership and pilot-to-scale plan. Useful for an early proposition, moving beyond pilots or introducing a digital offer. RMC works alongside your technical, clinical, information governance and regulatory specialists.
Sector perspective
NICE’s evidence standards framework connects a digital health technology’s value proposition with evidence and deployment considerations. It informs the commercial questions; specialist assessment and assurance remain with the relevant experts.